title: B cell or T cell-dominant recurrence after rituximab therapy in patients with SLE.
authors.forename: Shigeru
authors.initials: S
authors.lastname: Iwata
authors.forename: Kazuyoshi
authors.initials: K
authors.lastname: Saito
authors.forename: Mikiko
authors.initials: M
authors.lastname: Tokunaga
authors.forename: Yoshiya
authors.initials: Y
authors.lastname: Tanaka
mesh_terms: D000293:Adolescent; D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D001402:B-Lymphocytes / Q000276:immunology*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000276:immunology*; D012008:Recurrence; D000069283:Rituximab; D013601:T-Lymphocytes / Q000276:immunology*; D055815:Young Adult
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab